[1]
2023. Prevalence of persistent hypogammaglobulinemia in patients with autoimmune disease receiving rituximab at a national referral center in Mexico. Revista Alergia México. 69, 4 (Apr. 2023), 171–182. DOI:https://doi.org/10.29262/ram.v69i4.1142.